Pulmonary embolism
VTE · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Management
- Diagnose by clinical probability (H&P + a validated tool — Wells/Geneva). Low probability (< 15%) → apply PERC; if ALL criteria met, no further testing. Otherwise go to D-dimer.
- D-dimer with YEARS / age-adjusted cut-off (intermediate 15–50%): PE excluded if 0 YEARS criteria + D-dimer < 1000 ng/mL, OR ≥ 1 YEARS + D-dimer < 500 (or age-adjusted). Otherwise CTPA. High probability (> 50%) → straight to CTPA (bedside echo / POCUS if too unstable to move).
- 2026 AHA/ACC clinical category: A subclinical · B symptomatic, low severity · C symptomatic, elevated severity (RV strain / raised biomarkers) · D incipient cardiopulmonary failure (transient hypotension or normotensive shock) · E cardiopulmonary failure (persistent shock / arrest). Add the Respiratory modifier (R) for hypoxaemia, high-flow O₂ or ventilation.
- Anticoagulate early when suspicion is high and bleeding risk low: DOAC (apixaban / rivaroxaban) for Cat A/B low-risk; LMWH first-line for most inpatients, cancer and pregnancy; UFH if reperfusion is likely, the patient is unstable, or severe renal impairment.
- Risk-stratify Cat C–E: PESI / sPESI / HESTIA + RV assessment (echo or CT) + cardiac biomarkers (troponin, BNP) + lactate; activate the multidisciplinary PE Response Team (PERT).
- High-risk (Cat D–E): reperfuse if bleeding risk acceptable — systemic thrombolysis, OR catheter-directed lysis / mechanical thrombectomy; VA-ECMO or surgical embolectomy for refractory shock / arrest. Cautious fluid (≤ 500 mL) + early noradrenaline — do NOT over-fill the strained RV.
Drugs & doses
Apixaban / rivaroxaban (DOAC) — low-risk (Cat A/B) & most stable PE
LMWH e.g. enoxaparin 1.5 mg/kg OD (or 1 mg/kg BD) — inpatient, cancer, pregnancy
Unfractionated heparin — if thrombolysis likely, haemodynamic instability or severe renal impairment
Alteplase 100 mg IV over 2 h (50 mg if peri-arrest) — high-risk PE with acceptable bleeding risk
Noradrenaline for shock; cautious fluid ≤ 500 mL
Disposition
Cat A/B low-risk (PESI I–II / sPESI 0 / HESTIA negative) — consider outpatient DOAC. Cat C — admit, monitor, PERT. Cat D/E — HDU/ICU for reperfusion ± VA-ECMO.
2026 AHA/ACC classify acute PE by clinical category A–E (subclinical → cardiopulmonary failure) with a Respiratory modifier (R). The hypotensive / arresting patient (Cat D–E) dies from RV failure — reperfusion (thrombolysis or catheter therapy) is the resuscitation, not a last resort.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.